ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SDI Sdi Group Plc

66.00
-0.50 (-0.75%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Sdi Group Plc LSE:SDI London Ordinary Share GB00B3FBWW43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -0.75% 66.00 66.00 67.00 66.50 66.00 66.50 160,664 16:35:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 67.58M 3.87M 0.0372 17.88 69.19M
Sdi Group Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker SDI. The last closing price for Sdi was 66.50p. Over the last year, Sdi shares have traded in a share price range of 51.50p to 156.00p.

Sdi currently has 104,050,044 shares in issue. The market capitalisation of Sdi is £69.19 million. Sdi has a price to earnings ratio (PE ratio) of 17.88.

Sdi Share Discussion Threads

Showing 76 to 100 of 4100 messages
Chat Pages: Latest  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
09/8/2013
12:52
Interesting company. Joined AIM in Dec 2008 raising £2m @an IPO price of 12.5p. Since then they have issued 1.3m shares in acquiring Artemis and undertaken a placing of a further 4.8m shares in June @15p. This was to raise a further £850K in order to retire a convertible loan of £380k and to acquire more working capital. Current market cap is £4.3m based upon 24.2m shares in issue.

Their eps is around 1p and they had a positive net cash balance of just under £400K at their April year end. Chairman Ford recently bought 100,000 shares @16.5p but I'd like to see the CEO buy a bigger stake since a total holding of 7,500 shares is hardly inspiring. The business is nicely geographically segmented with circa 30% in the US, 30% in Europe (ex-UK), 25% in Asia and 10% in the UK although that should increase further following the recent adoption of ProReveal at Eastwood Park.

On to my Watchlist at this point as it looks as though it may be on the cusp of some accelerated growth.

masurenguy
06/8/2013
11:50
Had a little nibble here today. Prospects look very interesting and if the forecast are to be believed and achieved then it looks very undervalued particularly with market leading position on some of it's products.

If ProReveal sells at anything like it's potential it should multibag from here. And there does seem to be a good global distribution set up too.

Although cash flow from operations was decent there's not a lot of cash on the balance sheet even allowing for the placing and loan repayment so managing the working capital requirements is going to be very important.

The only down side i can see is the spread and illiquidity but that may well work in our favour if the mm's become short of stock. We may see a further placing possibly dependant on cash flows and WC requirements.

One to put away for the longer term perhaps and maybe build as time goes on.

Woody

woodcutter
26/7/2013
10:59
Their main product which will sell like hot cakes is ProReveal.

See this article from Journal of Hospital published earlier this year


This confirms that Ninhydrin kits, currently used in hospitals are ineffective at detecting residual proteins. The way forward is SDI ProReveal which has got the first mover advantage.

nick2008
26/7/2013
08:05
Good morning all
nick2008
25/7/2013
17:25
Strange !! There is a buy at 21p - single buy trade yet the price drops down.
nick2008
25/7/2013
14:59
Extracts from Results

- We believe that the recent SFDA order independently validates our technology as the "gold standard" and consider that our growth in Asia will continue to be fuelled by their need for excellent automation in the life sciences.


- ProReveal is the only technology currently available that can meet nanogram levels of detection and could potentially be installed in 300 SSD's, in hospitals and private decontamination companies throughout the UK.


- In 2013, 10 ProReveal systems were sold in the UK and Synoptics Health's UK distributor has installed three ProReveal systems in two major SSD's of leading London hospitals and one in an NHS training facility.


- Synoptics Health is currently enjoying a first mover advantage in this untapped healthcare market sector not just in the UK but internationally.

- During the period, the Synoptics Health Division appointed a network of six new distributors throughout the Asia-Pacific region

- In Europe, the Division has appointed a new distributor in Germany and sold four systems, which are being independently evaluated by German hospitals. There are plans to have Dutch and Italian distributors in place, as well as a North American distributor within the next few months ensuring growth in demand for the ProReveal viewer and more importantly, a recurring revenue stream for the ProReveal spray over the coming year.

nick2008
25/7/2013
14:53
Wow! now Mike Creedon, Chief Executive Officer of the Company buys the stock...

Note that Mike was the NEW CEO last year who has been turning around this company.

nick2008
24/7/2013
20:03
This is tightly held stock, so doesn't take much buying to push the price up. We'll see more buying this week. DYORNick.
nick2008
24/7/2013
11:08
25k buy @20p went through....
nick2008
24/7/2013
10:43
Another director buy at 16.5p. RNS out now.
nick2008
24/7/2013
10:14
Plus a very encouraging results RNS.
gnnmartin
24/7/2013
08:14
RNS out - SDI is pleased to announce that the major international healthcare training centre, Eastwood Park, UK will be using ProReveal, a test to detect proteins on surgical instruments, to supplement the training of validation professionals on how to assess the efficacy of the decontamination processes.
nick2008
12/7/2013
23:02
Good buying today.
nick2008
28/6/2013
15:57
Strange to fall today?
nick2008
28/6/2013
14:58
hastings, thanks. I looked in today to see what's hit the shares. No news yet though. Very odd.
Nigel Martin

gnnmartin
23/6/2013
21:45
Well Nigel, I guess mkt expectations are in line with the house broker as below
FinnCap 20-06-13 CORP pre tax 0.20 eps3.80 - 0.40 4.80 Fwd PER of 6 and falling!

May be of interest.
hxxp://www.cambridge-news.co.uk/Business/Business-News/Life-saving-nano-firm-gets-850k-20130621152649.htm

hastings
21/6/2013
13:39
A disappointingly deep discount for the placing. Results to be "in line with market expectations", which is one of my pet hates. If, for whatever reason, they do not say what "market expectations" are then they should not be allowed to say they expect to meet market expectations.
Nigel Martin

Edit: on reading further, they were rather over a barrel, needing to raise the money to pay off the convertible at the end of July.

gnnmartin
21/6/2013
13:19
Equity issue and trading update - see the RNS.
nick2008
17/4/2013
22:21
Enjoyed a good run Nick and hopefully continue that way.
hastings
17/4/2013
21:42
This has held its price steady. This month marks the end of trading year. Let's hope for trading update early next month. Nick.
nick2008
18/3/2013
19:01
Buying continues @27p......
nick2008
15/3/2013
18:13
Some good buying through in the last few days. MMs will be short at this rate......Nick
nick2008
08/3/2013
10:15
Nick2008 7 Feb'13 - 13:36 - 19 of 28 0 0 edit

For me, the best sales initiative for their new product ProReveal is to appoint Peskett Solutions Ltd as the sole UK Distributor.

ProReveal product is 100 times more senstive than the current tests, so I'm sure RUHOF would have heard about it through their own UK Distributor - Peskett Solutions.

There is no conflict of interest between RUHOF & SDI. RUHOF's product is used for cleaning the instruments and SDI detects the protein on them after cleaning. If the cleaning is below a certain threshold, then all the instruments have to be cleaned again using RUHOF cleaning product.

RUHOF is large organisation with worldwide dealers and distribution centres. I won't surprised if RUHOF themselves would be keen to sell SDI products outside UK, using their own channels....




Evidence that RUHOF themselves are keen to sell SDI products outside UK, using their own channels -


1. See the report presentation from Dr.N.K.Nayuni - one the scientists who invented the ProReveal detection - to Ruhuf. Pls have a look at appendix B for reference of ProReveal



2. SDI patent link show the inventors including Dr.N.K.Nayuni.



Inventor(s) list and link


PERRETT, David
NAYUNI, Nanda Kishore;
ELLWOOD, Paul;
MASKELL, Richard;
WRIGHT, Alastair Hayden;
THOMPSON, Sarah;
SULLIVAN, Laura;


Note that one of inventor is Paul Ellwood, the CEO of Synoptics - One of subsidiary of SDI.

nick2008
27/2/2013
13:50
Nice spot Nick.
hastings
26/2/2013
14:01
Another article highlighting that existing methods of detecting proteins on the surgical instruments are ineffective and that this will be changed in the NHS guidelines as well. SDI uses the new 'to be recommended' NHS guidelines to detect proteins - Detection using fluorescence

The problem of protein: how clean is 'clean'? - Feb 2013


The above article makes reference to ProReveal - the SDI detection tool which was launched in Dec-2012.

nick2008
Chat Pages: Latest  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock